Understanding how BIN1 affects brain cell function in Alzheimer's disease

Unlocking BIN1 function in oligodendrocytes and support of axon integrity

NIH-funded research Texas A&m Agrilife Research · NIH-10901005

This study is looking at how a protein called BIN1 affects brain cells that help keep nerve fibers healthy, to see if changes in these cells might play a role in the early stages of Alzheimer's disease, even before symptoms show up.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTexas A&m Agrilife Research NIH-funded
Lab location1 site (College Station, UNITED STATES)
Project IDNIH-10901005 on NIH RePORTER

What this research studies

This research investigates the role of a protein called BIN1 in oligodendrocytes, which are cells that support the health of nerve fibers in the brain. The study focuses on how changes in these cells may contribute to the early stages of Alzheimer's disease, particularly before the more recognizable symptoms appear. By examining the cellular mechanisms involved, the researchers aim to uncover how BIN1 influences the integrity of axons, the long projections of nerve cells that are crucial for communication in the brain. This could lead to new insights into the disease process and potential therapeutic targets.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults aged 21 and older who are at risk for or diagnosed with late-onset Alzheimer's disease.

Not a fit: Patients with early-onset Alzheimer's disease or those without any cognitive impairment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease by targeting the underlying cellular mechanisms involved in nerve cell health.

How similar studies have performed: While the specific role of BIN1 in oligodendrocytes is less explored, similar research has shown that targeting cellular mechanisms in neurodegenerative diseases can yield promising results.

Where this research is happening

College Station, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.